source
- Revolution Medicines threatens lawsuit against Erasca over RAS drug patent and efficacy claimsEarlier this month a newly announced cancer therapy generated strong interest from patients and investors. The drug, which targets the RAS pathway, was highlighted for its potential impact on oncol…
- Utah doctors urge state to suspend Doctronic AI prescription-refill programUtah medical licensing board members have asked the state to halt a temporary program that lets startup Doctronic use artificial intelligence to refill prescriptions. The board says the AI-driven…